Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

Genentech, Novo Nordisk and AbbVie top the list of best workplaces in biopharma
Fierce Pharma
Fri, 04/17/20 - 11:30 pm
Tags:
Roche, Genentech, Novo Nordisk, AbbVie, Fortune, employees
AbbVie, Pfizer, Novartis and more pledge millions in COVID-19 disaster relief
Fierce Pharma
Mon, 04/6/20 - 09:36 pm
Tags:
COVID-19, pandemic, philanthropy, AbbVie, Pfizer, Novartis
A Covid-19 threat to business acquisitions
EP Vantage
Thu, 04/2/20 - 11:57 am
Tags:
COVID-19, M&A, AbbVie, Allergan, Arya Sciences, Immatics, AcelRx, Tetraphase, Gilead Sciences, Forty Seven, Thermo Fisher, Stryker, Wright Medical
AbbVie announces positive topline results from phase 3 trial of VENCLEXTA, Azacitidine combo in AML
Pharmaceutical Business Review
Tue, 03/24/20 - 10:45 am
Tags:
AbbVie, Venclexta, azacitidine, clinical trials, AML
Go or no go? Covid-19 upstages US regulatory decisions
EP Vantage
Tue, 03/24/20 - 10:30 am
Tags:
FDA, regulatory, Bristol-Myers Squibb, ozanimod, Esteve, E-58425, Fabre-Kramer, AstraZeneca, Imfinzi, Astellas, Vesicare, AbbVie, Neurocrine, Orlissa, Sanofi, MenQuadfi, opicapone, Acceleron, Reblozyl
AbbVie gives up patent rights to HIV med Kaletra amid COVID-19 tests: report
Fierce Pharma
Mon, 03/23/20 - 11:37 pm
Tags:
AbbVie, HIV, Kaletra, patents, COVID-19
AbbVie, Roche's Venclexta nails confirmatory combo trial in AML after flopping earlier study
Fierce Pharma
Mon, 03/23/20 - 11:53 am
Tags:
AbbVie, Roche, Venclexta, AML, clinical trials
AbbVie will allow generic copies of its HIV pill in Israel after the government approved a license
Stat
Sat, 03/21/20 - 12:05 am
Tags:
AbbVie, Kaletra, generics, Israel, COVID-19
New data from randomized trial dent HIV drug strategy against Covid-19
Endpoints
Thu, 03/19/20 - 10:55 am
Tags:
Kaletra, AbbVie, COVID-19, clinical trials
AbbVie and Allergan Sign Divestiture Consent Decree with FTC, Move Closer to Finalizing Merger
BioSpace
Thu, 03/19/20 - 12:01 am
Tags:
AbbVie, Allergan, FTC, M&A
AbbVie, Allergan merger may face regulatory delay due to COVID-19: report
Fierce Pharma
Tue, 03/17/20 - 11:32 pm
Tags:
AbbVie, Allergan, FTC, M&A, COVID-19
AbbVie to Test HIV Drug as a Potential Coronavirus Treatment
Motley Fool
Tue, 03/10/20 - 11:03 am
Tags:
AbbVie, Kaletra, COVID-19, coronaviruses, HIV
Bristol Myers flunks frontline multiple myeloma trial, turning attention to cell therapy
Endpoints
Mon, 03/9/20 - 10:52 am
Tags:
Bristol-Myers Squibb, Celgene, M&A, clinical trials, Multiple Myeloma, Empliciti, AbbVie, Revlimid
European regulators expand use of AbbVie's two-month hep C regimen
Endpoints
Fri, 03/6/20 - 10:39 am
Tags:
AbbVie, Europe, hepatitis C, Maviret
AbbVie and Allergan finally set (rough) date for wedding as one parent agrees to the match
Endpoints
Wed, 03/4/20 - 10:54 am
Tags:
AbbVie, Allergan, M&A
AbbVie, Roche's Venclexta endangers AML approval with flopped confirmatory trial
Fierce Pharma
Mon, 03/2/20 - 11:07 pm
Tags:
AbbVie, Roche, Venclexta, AML, blood cancer, FDA
Biohaven scores CGRP OK for acute migraine — can the commercial team catch up with Allergan on its debut?
Endpoints
Thu, 02/27/20 - 11:46 pm
Tags:
Biohaven, FDA, migraines, Nurtec, Allergan, AbbVie, Ubrelvy
Biotech Q4 Earnings Synopsis: Major Restructuring and Overall Growth Are Themes
BioSpace
Mon, 02/10/20 - 10:19 am
Tags:
earnings, Bristol-Myers Squibb, AbbVie, Novo Nordisk, Merck, GSK, Seattle Genetics
AbbVie touts Humira defense strategy abroad as a positive sign for forthcoming U.S. battle
Fierce Pharma
Sun, 02/9/20 - 04:19 pm
Tags:
AbbVie, Humira, generics, patents
AbbVie's plan to replace Humira is ahead of schedule
BioPharma Dive
Fri, 02/7/20 - 11:48 pm
Tags:
AbbVie, Humira, Skyrizi, immunology

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.